Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating tumor-associated autoantibody signatures for diagnosis and prognosis in small-cell lung cancer and lung adenocarcinoma.

British journal of cancer·2026
Same author

A case of recurrent breast cancer with severe hepatic dysfunction: Integrating narrative-based medicine and clinical decision-making.

Palliative & supportive care·2026
Same author

Proteome-wide autoantibody screening and holistic autoantigenomic analysis unveil COVID-19 signature of autoantibody landscape.

BMC immunology·2026
Same author

Comment on "Gastric Antral Vascular Ectasia in Systemic Sclerosis": Clinical Insights From Two Japanese Cohort Studies.

The Journal of dermatology·2026
Same author

Facial Skin Care Instruction by Medical Professionals Using Microneedle Cream: The 8-Week Prospective, Randomized, Single-Blinded for Examiners Trial in Asians.

Journal of cosmetic dermatology·2026
Same author

An Exploratory Study of Machine Learning-Based Open-Angle Glaucoma Detection Using Specific Autoantibodies.

Biomedicines·2025

Related Experiment Video

Updated: Jul 15, 2025

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
10:16

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies

Published on: September 15, 2016

12.9K

The Autoantibody Array Assay: A Novel Autoantibody Detection Method.

Yuta Norimatsu1,2, Kazuki Mitsuru Matsuda1, Kei Yamaguchi3,4

  • 1Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan.

Diagnostics (Basel, Switzerland)
|September 28, 2023
PubMed
Summary
This summary is machine-generated.

A new method called A-cube, using cell-free protein synthesis, effectively detects autoantibodies in systemic sclerosis (SSc) and dermatomyositis (DM). This innovative technique shows comparable or superior accuracy to existing methods for diagnosing these autoimmune diseases.

Keywords:
autoimmune collagen diseasescell-free protein synthesisdermatomyositissystemic sclerosis

More Related Videos

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

2.6K
Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.5K

Related Experiment Videos

Last Updated: Jul 15, 2025

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
10:16

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies

Published on: September 15, 2016

12.9K
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

2.6K
Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.5K

Area of Science:

  • Immunology
  • Biochemistry
  • Molecular Biology

Background:

  • Systemic sclerosis (SSc) and dermatomyositis (DM) are autoimmune collagen diseases.
  • Specific autoantibodies are crucial in their pathogenesis, influencing clinical presentation.
  • Current gold standard autoantibody detection (immunoprecipitation) is limited by radioisotope use.

Purpose of the Study:

  • To develop and validate a novel detection method for SSc and DM autoantibodies.
  • To assess the utility of cell-free protein synthesis for autoantibody detection.
  • To compare the new method's performance against established diagnostic techniques.

Main Methods:

  • Development of the A-cube assay utilizing wheat germ cell-free protein synthesis.
  • Testing of 100 SSc cases, 50 DM cases, and 82 healthy controls.
  • Validation through comparison with existing autoantibody test results.

Main Results:

  • The A-cube method demonstrated comparable or superior sensitivity and specificity to existing tests.
  • The assay successfully detected various autoantibodies including anti-centromere, anti-topoisomerase I, and anti-Jo-1.
  • A case study highlighted the A-cube's potential to influence diagnostic reconsiderations.

Conclusions:

  • The A-cube method is a valid and reliable tool for detecting SSc and DM autoantibodies.
  • Its high quality and comprehensive analysis capabilities support clinical assessment and treatment.
  • This cell-free protein synthesis-based approach offers a promising alternative for autoimmune disease diagnostics.